Illumina, Inc. (ILMN) at a glance

Illumina, Inc. (ILMN) is a large-cap Healthcare company. It trades at $207.72, with a P/E of 29.2, a 19.4% profit margin and revenue growth of 4.8%. It does not pay a dividend. Vestovix scores it 43/100 overall. Its strongest dimension is Momentum (74/100) and its weakest is Safety (24/100). It carries above-market volatility, so expect larger swings.

Price

$207.72

Market cap

$24.35B

P/E ratio

29.2

Dividend yield

None

Beta

1.49

52-week range

$88.00 to $231.81